Search results
Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL...
The Herald Journal· 7 days agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that Phase 2 results on LPCN 1148 in cirrhosis were featured in a late breaking oral presentation at the European Association ...
Bares Capital Management Inc. Increases Stock Holdings in Zuora, Inc. (NYSE:ZUO)
ETF DAILY NEWS· 4 days agoBares Capital Management Inc. lifted its stake in Zuora, Inc. (NYSE:ZUO – Free Report) by 54.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The ...
Barton Completes $490,000 Gold Sale
Digital Journal· 2 days agoTreasury Boosted by Mill Cleanup & Record AUD Gold Prices ADELAIDE, AUSTRALIA / ACCESSWIRE / June 14, 2024 /HIGHLIGHTSSale of ~165 ounces gold for total proceeds of ~$490,000Realised price of ...